CSP Exam Test (Specialty pharmacy) With 100%Correct Answers!!

CSP Exam Test (Specialty pharmacy) With 100%Correct Answers!! PDC calculation - Correct Answer-PDC = (# of unique days with supply / number of days in a period) x 100 Which medication is a Jak inhibitor? a. Humira (adalimumab) b. Orencia (abatacept) c. Actemra (toclizumab) d. Xeljanz (tofacitinib) - Correct Answer-d. Xeljanz (tofacitinib) Which medication can elevate cholesterol? a. Actemra (toclizumab) b. Enbrel (etanercept) c. Simponi (golimumab) d. Kineret (anakinra) - Correct Answer-a. Actemra (toclizumab) Which shingles vaccine is safe to administer with TNF inhibitors? a. Adacel b. Zostavax c. Shingrix d. Varivax - Correct Answer-c. Shingrix Most biologics increase the risk of infections, which of the following also increases the risk of neutropenia? a. Rituxin (rituximab) b. Taltz (ixekizumab) c. Remicade (infliximab) d. Cimzia (certolizumab pegol) - Correct Answer-b. Taltz (ixekizumab) Which psoriasis medication does not require screening for tuberculosis? a. Stelara (ustekinumab) b. Otezla (apremilast) c. Cocentyx (seculinumab) d. Humira (adalimumab) - Correct Answer-b. Otezla (apremilast) What is the standard starting dose for Taltz (ixekizumab) when used to treat psoriatic arthritis? a. 160mg subcutaneously once, followed by 80mg subcutaneously at weeks 2, 4, 6, 8, 10 and 12; then 80mg subcutaneously every 4 weeks CSP Exam Test (Speciality pharmacy) With 100%Correct Answers!! b. 160mg subcutaneously once, followed by 80mg subcutaneously every 4 weeks c. 160mg subcutaneously once, followed by 80mg subcutaneously every week for 4 weeks, then 80mg every 4 weeks d. 160mg subcutaneously once, followed by 80mg subcutaneously every other week - Correct Answer-b. 160mg subcutaneously once, followed by 80mg subcutaneously every 4 weeks A 45 y/o, 200lb patient is struggling with severe dermatitis and the provider wants to potentially start a biologic. Which medication would you recommend? a. Protopic (tacrolimus) b. Humira (adalimumab) c. Stelara (ustekinumab) d. Dupixent (dupilumab) - Correct Answer-d. Dupixent (dupilumab) A 56 y/o, 140lb patient with psoriasis will be starting Stelara (ustekinumab), but the provider wants to verify the dosing of the medication. What starting dose would you recommend? a. Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45 mg every 12 weeks b. Inject 90 mg subcutaneously at weeks 0 and 4, followed by 90 mg every 12 weeks c. Infuse 260 mg IV over at least 1 hour as a single dose, followed 8 weeks later with 90 mg subcutaneously every 8 weeks d. Infuse 520 mg IV over at least 1 hour as a single dose, followed 8 weeks later with 90 mg subcutaneously every 8 weeks - Correct Answer-a. Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45 mg every 12 weeks.